CD138 + MUM1 Staining for Chronic Endometritis:
Introduction:
CD138 + MUM1 Staining for Chronic Endometritis is a specialized diagnostic procedure developed to improve the identification of chronic inflammatory conditions affecting the endometrial lining of the uterus. Chronic Endometritis is often a subtle and persistent inflammatory disorder that may remain undetected during routine microscopic examination because the inflammatory cells responsible for the condition can be difficult to recognize clearly. Despite its silent nature, this condition can significantly affect reproductive health by interfering with embryo implantation, increasing the likelihood of recurrent miscarriages, contributing to repeated IVF failure, and causing unexplained infertility in many women. The combination of CD138 and MUM1 immunohistochemistry markers provides a more advanced and sensitive approach for identifying plasma cells within endometrial tissue, allowing pathologists to detect chronic inflammation with greater diagnostic confidence. CD138 highlights plasma cells present in the tissue, while MUM1 serves as an additional marker that supports clearer identification and improved interpretation of inflammatory activity.
This dual-marker staining technique enhances the overall accuracy of endometrial evaluation and helps healthcare providers understand the underlying cause of persistent reproductive and gynecological problems. The test is especially valuable for women who have experienced multiple unsuccessful fertility treatments, repeated pregnancy loss, unexplained uterine symptoms, or abnormal endometrial findings during fertility assessment. By identifying hidden inflammatory changes within the uterine lining, CD138 + MUM1 staining helps guide targeted treatment strategies aimed at restoring healthier endometrial function and improving reproductive outcomes.
What is CD138 + MUM1 Staining for Chronic Endometritis?
CD138 + MUM1 Staining for Chronic Endometritis is an advanced immunohistochemistry-based laboratory test used to identify chronic inflammation within the endometrial lining of the uterus. This specialized diagnostic method combines two markers, CD138 and MUM1, to improve the detection of plasma cells and inflammatory changes that may not always be visible during routine histopathological examination. Chronic Endometritis is often associated with infertility, recurrent miscarriages, repeated IVF failure, abnormal uterine bleeding, and unexplained reproductive difficulties. By using dual-marker staining, pathologists can evaluate endometrial tissue with greater precision and provide a more reliable diagnosis. The test plays an important role in helping doctors identify hidden inflammation and guide suitable treatment strategies for improving uterine health and reproductive outcomes.
What is the cost of CD138 + MUM1 Staining for Chronic Endometritis?
The cost of CD138 + MUM1 Staining for Chronic Endometritis is ₹6,500. This pricing includes specialized immunohistochemistry staining, microscopic tissue evaluation, dual-marker analysis, and expert pathological interpretation aimed at accurately identifying chronic inflammatory changes within the endometrium.
Why are CD138 and MUM1 markers used together?
CD138 and MUM1 are used together because combining these markers improves the accuracy of identifying plasma cells associated with chronic inflammation in the endometrium. CD138 is a well-known plasma cell marker, while MUM1 supports additional confirmation of plasma cell presence and cellular activity. Using both markers together increases diagnostic sensitivity and reduces the chances of missing subtle inflammatory changes. This dual staining approach helps pathologists distinguish chronic inflammatory cells more clearly from surrounding tissue structures, resulting in a more dependable diagnosis for women with unexplained fertility or gynecological problems.
What is Chronic Endometritis?
Chronic Endometritis is a persistent inflammatory condition affecting the inner lining of the uterus known as the endometrium. Unlike acute infections, this condition often develops slowly and may produce very mild symptoms or remain completely silent. Many women with Chronic Endometritis experience infertility, recurrent pregnancy loss, implantation failure during IVF cycles, abnormal bleeding, or pelvic discomfort without knowing the underlying reason. Chronic inflammation can interfere with normal endometrial function and reduce the ability of the uterus to support successful implantation and pregnancy. Accurate diagnosis through specialized staining methods helps identify the condition early and supports effective treatment.
Who should undergo CD138 + MUM1 staining?
Women with unexplained infertility, repeated IVF failure, recurrent miscarriages, persistent abnormal uterine bleeding, or chronic pelvic discomfort may be advised to undergo CD138 + MUM1 staining. Doctors may also recommend this test when routine histopathology findings are inconclusive but clinical suspicion for Chronic Endometritis remains high. Patients with a history of recurrent implantation failure or unsuccessful fertility treatments often benefit from detailed endometrial evaluation using advanced immunohistochemistry markers.
How is the sample collected for this test?
The tissue sample is usually collected through an endometrial biopsy, hysteroscopy-guided biopsy, or dilation and curettage procedure. A small portion of the endometrial lining is carefully removed and sent to the pathology laboratory for immunohistochemistry staining and microscopic analysis. The procedure is generally completed within a short duration, and most patients are able to return home the same day. Proper sample collection is important to ensure accurate evaluation of inflammatory cells within the endometrial tissue.
Can Chronic Endometritis affect pregnancy outcomes?
Yes, Chronic Endometritis can negatively affect pregnancy outcomes by interfering with implantation and early embryo development. Persistent inflammation within the uterine lining may reduce endometrial receptivity and increase the risk of implantation failure or recurrent miscarriage. Some women undergoing fertility treatment may experience repeated unsuccessful cycles because underlying chronic inflammation remains undiagnosed. Identifying and treating Chronic Endometritis can improve the uterine environment and support healthier reproductive outcomes.
Why is this test important for IVF patients?
This CD138 + MUM1 staining test is especially valuable for IVF patients because hidden inflammation within the endometrium can reduce the chances of embryo implantation even when embryo quality is good. Women experiencing repeated IVF failure often undergo advanced endometrial evaluation to identify possible causes affecting implantation success. CD138 + MUM1 staining helps detect subtle inflammatory changes that may not appear on routine testing, allowing doctors to treat the condition before future embryo transfer procedures.
How accurate is CD138 + MUM1 staining?
CD138 + MUM1 staining is considered highly accurate for identifying plasma cells and chronic inflammatory activity within endometrial tissue. The use of dual immunohistochemistry markers increases diagnostic precision and improves the ability to detect subtle inflammatory changes. Accurate diagnosis is essential because untreated Chronic Endometritis may continue affecting fertility and reproductive outcomes. Expert pathological interpretation further enhances the reliability of the test findings.
Can this test help identify hidden uterine inflammation?
Yes, this CD138 + MUM1 staining test is specifically designed to identify hidden chronic inflammation that may not be clearly visible during routine microscopic evaluation. Chronic Endometritis often remains undiagnosed because plasma cells can be sparse and difficult to identify using conventional staining methods. CD138 + MUM1 staining highlights these inflammatory cells more effectively, helping pathologists confirm the presence of chronic inflammation within the uterine lining.
Is the biopsy procedure painful?
Some women may experience mild cramping or temporary discomfort during endometrial biopsy procedures. The level of discomfort varies between individuals and depends on the sampling technique used. In most cases, the discomfort is short-lived and manageable. Mild spotting or cramping may continue briefly after the procedure, but serious complications are uncommon when performed by experienced healthcare professionals.
Can this test improve fertility treatment planning?
Yes, identifying Chronic Endometritis through CD138 + MUM1 staining allows fertility specialists to create more targeted treatment plans before proceeding with IVF or other reproductive procedures. Treating underlying inflammation may improve implantation rates and reduce the likelihood of repeated fertility treatment failure. Accurate diagnosis also helps doctors decide whether additional medical management or follow-up evaluation is necessary before future pregnancy attempts.
Is fasting required before sample collection?
Fasting is generally not required before undergoing endometrial biopsy or CD138 + MUM1 staining procedures. However, patients should follow any specific preparation instructions provided by their healthcare provider. Informing the doctor about ongoing medications, pregnancy status, allergies, or existing medical conditions is important before the procedure to ensure safe and effective sample collection.
How long does it take to receive the results?
The turnaround time for this test may take 3 to 6 days or it may vary depending on laboratory processing and the complexity of immunohistochemistry analysis. Since the tissue requires specialized staining and detailed microscopic interpretation, several days may be needed before the final report is prepared. Patients are encouraged to review the findings with their healthcare provider for complete understanding and treatment guidance.
Can Chronic Endometritis return after treatment?
In some cases, Chronic Endometritis may recur, especially if the underlying cause remains unresolved. Persistent infections, retained tissue, or repeated uterine procedures may contribute to recurrence. Follow-up medical evaluation may be recommended in selected cases to confirm that inflammation has resolved successfully after treatment. Continued monitoring helps reduce the risk of persistent reproductive complications.
What role do plasma cells play in diagnosis?
Plasma cells are specialized immune cells that indicate chronic inflammation when found within the endometrial tissue. Their presence is considered an important diagnostic feature of Chronic Endometritis. Because plasma cells may be difficult to identify with routine staining methods, immunohistochemistry markers such as CD138 and MUM1 help highlight them clearly under microscopic examination, improving diagnostic accuracy.
Can this test be used for recurrent miscarriage evaluation?
Yes, CD138 + MUM1 staining is frequently used during the evaluation of recurrent pregnancy loss because chronic endometrial inflammation may interfere with normal embryo implantation and pregnancy progression. Identifying and treating hidden inflammation may improve the uterine environment and reduce the risk of repeated miscarriage in some women experiencing unexplained reproductive loss.
Are the results confidential?
Yes, patient confidentiality is maintained throughout the testing and reporting process. Diagnostic laboratories follow strict privacy protocols to protect medical information and laboratory findings. Reports are generally shared only with authorized healthcare professionals or individuals approved by the patient, ensuring secure handling of sensitive reproductive health information.
Why is early diagnosis of Chronic Endometritis important?
Early diagnosis is important because untreated chronic inflammation can continue affecting fertility, implantation success, and reproductive health over time. Delayed diagnosis may contribute to repeated IVF failure, recurrent pregnancy loss, or persistent gynecological symptoms. Timely identification through advanced staining methods allows doctors to begin treatment earlier and improve the chances of successful pregnancy and healthier uterine function.
Why should patients choose CD138 + MUM1 Staining for Chronic Endometritis?
CD138 + MUM1 Staining provides a highly detailed and accurate approach for detecting chronic inflammation within the endometrial lining. By combining dual immunohistochemistry markers, the test improves the visibility of plasma cells and enhances diagnostic precision compared to routine tissue examination alone. Accurate identification of Chronic Endometritis supports targeted treatment, improved fertility planning, better implantation outcomes, and personalized reproductive care. With advanced laboratory technology and expert pathological interpretation, this test serves as a valuable diagnostic tool for women experiencing unexplained fertility challenges and persistent endometrial abnormalities.
Conclusion:
CD138 + MUM1 Staining for Chronic Endometritis serves as an important diagnostic advancement in the evaluation of persistent endometrial inflammation and reproductive health disorders. Through the use of dual immunohistochemistry markers, this test provides enhanced visibility of plasma cells and improves the detection of chronic inflammatory changes that may not be identified through routine histopathological examination alone. Accurate diagnosis of Chronic Endometritis is extremely important because untreated inflammation can continue to interfere with embryo implantation, fertility treatment success, and normal pregnancy progression. By offering more detailed and reliable tissue analysis, this specialized staining method helps physicians develop individualized treatment plans designed to improve uterine health and reproductive outcomes.
